Data indicate that replicating cells might be vulnerable to cell death at exposure to the ROR1 inhibitor KAN0441571C and/or that KAN0441571C induced a cytostatic effect in lung cancer cells preventing exit from G2/M phase and cell proliferation (Figure S4). This evidence concerns the gene ROR1 and lung carcinoma.